Ethiraj, Purushoth <br/><br/>
Interferon β improves the efficacy of low dose cisplatin by inhibiting NF-κB/p-Akt signaling on HeLa cells.  [electronic resource] 

 -  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  Aug 2016 
 - 124-32 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1950-6007 
<br/><br/><label>Standard No.: </label>10.1016/j.biopha.2016.04.058  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Cell Nucleus--drug effects<br/>Cell Proliferation--drug effects<br/>Cisplatin--pharmacology<br/>Dose-Response Relationship, Drug<br/>Drug Synergism<br/>HeLa Cells<br/>Humans<br/>I-kappa B Proteins--metabolism<br/>Interferon-beta--pharmacology<br/>Matrix Metalloproteinase 9--metabolism<br/>Micronucleus, Germline--drug effects<br/>NF-kappa B--metabolism<br/>Phosphorylation--drug effects<br/>Poly(ADP-ribose) Polymerases--metabolism<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>STAT2 Transcription Factor--metabolism<br/>Signal Transduction--drug effects